Loading organizations...
Key people at Guozhong Capital.
Guozhong Capital is a venture capital firm based in Shenzhen, Guangdong, China, investing in innovative small and medium-sized enterprises across technology, biomedical, healthcare, TMT, manufacturing, semiconductors, and medical fields. It manages the 6 billion Yuan National Small Medium Enterprises Development Fund, with its three-member management team holding a 51% stake and Shenzhen Venture Capital Group the remaining 49% of its 100 million Yuan registered capital. Its portfolio features companies like PIX Moving (Series B funding) and Baiwang (IPO July 2024). Empyrean Technology (EDA software) listed on the Growth Enterprise Market in July 2022, achieving a 40.72 billion Yuan market value. Managing Director Wei Jia, Partner Ma Ruopeng, and TMT investment director Yang Yang lead the firm, founded in December 2015.
Guozhong Capital has 7 tracked investments across 7 companies. The latest tracked deal is $14.3M Series A in Errui Xinyue in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 26, 2025 | Errui Xinyue | $14.3M Series A | Guozhong Capital | — |
| Dec 8, 2025 | EngineAI Robotics | $141.4M Series A | Huangpu River Capital | Cctv Fund, Fortune Capital, Henan Investment Group, Hunan Caixin Investment Holding Group, Nanshan SEI Investment, Stone Ventures, TH Capital, Welkin, Xingyuan Capital |
| Nov 29, 2023 | Simetric Semiconductor | $14.0M Series A | Guozhong Capital | Zhongxin Chuangtou |
| Nov 1, 2023 | Hydrogen Energy | $13.7M Series A | Guozhong Capital | — |
| Jun 1, 2023 | Aibo Medical Robot | $14.1M Series A | Guozhong Capital | Xiaodong Jiang |
| Oct 12, 2021 | Chance Pharmaceuticals | $30.0M Series C | Zhihua YU | HEDA BioVenture |
| Feb 28, 2020 | Ascentawits | $14.3M Series A | Guozhong Capital | — |
Key people at Guozhong Capital.
